Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adenine 1
- Administration, Oral 1
- Adolescent 1
- Adult 2
- Anti-HIV Agents 4
- Anti-Retroviral Agents 1
- antiretroviral agents 2
- Article 4
- Biomarkers 1
- Child 1
- Cobicistat 2
- COVID-19 1
- COVID-19 Vaccines 1
- District of Columbia 1
- dried blood spot 1
- Emtricitabine 3
- Gastrointestinal Microbiome 1
- HIV 1
- HIV-1 1
- HIV Infections 4
- Homosexuality, Male 2
- Humans 5
- Lubricants 1
- Male 4
- men who have sex with men 2
- Middle Aged 2
- Parents 1
- Pharmaceutical Preparations 2
- Point-of-Care Systems 1
- point-of-care test 1
- point-of-care testing 1
- Pre-Exposure Prophylaxis 1
- pre-exposure prophylaxis 1
- PrEP 1
- Quinolones 1
- Rectum 1
- Sexual and Gender Minorities 1
- Students 1
- Tenofovir 2
- Time Factors 1
- Urethra 1
- urine 2
- Vaccination 1
- Young Adult 1
Personal Author
Resource Type General
Keywords
- Adolescent 1
- Adult 1
- Anti-HIV Agents 1
- COVID-19 1
- District of Columbia 1
- Emtricitabine 1
- Heterocyclic Compounds, 3-Ring 1
- HIV Infections 1
- HIV Integrase Inhibitors 1
- Homosexuality, Male 1
- Humans 1
- Integrases 1
- K-12 schools 1
- Male 1
- Middle Aged 1
- Pyridones 1
- racial/ethnicity disparities 1
- Sexual and Gender Minorities 1
- time-to-event 1
- vaccine hesitancy 1
- Young Adult 1
Select all docs (Max 200)
1 -
7 of 7 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adenine (1)
- Administration, Oral (1)
- Adolescent (1)
- Adult (2)
- Anti-HIV Agents (4)
- Anti-Retroviral Agents (1)
- antiretroviral agents (2)
- Article (4)
- Biomarkers (1)
- Child (1)
- Cobicistat (2)
- COVID-19 (1)
- COVID-19 Vaccines (1)
- District of Columbia (1)
- dried blood spot (1)
- Emtricitabine (3)
- Gastrointestinal Microbiome (1)
- HIV (1)
- HIV-1 (1)
- HIV Infections (4)
- Homosexuality, Male (2)
- Humans (5)
- Lubricants (1)
- Male (4)
- men who have sex with men (2)
- Middle Aged (2)
- Parents (1)
- Pharmaceutical Preparations (2)
- Point-of-Care Systems (1)
- point-of-care test (1)
- point-of-care testing (1)
- Pre-Exposure Prophylaxis (1)
- pre-exposure prophylaxis (1)
- PrEP (1)
- Quinolones (1)
- Rectum (1)
- Sexual and Gender Minorities (1)
- Students (1)
- Tenofovir (2)
- Time Factors (1)
- Urethra (1)
- urine (2)
- Vaccination (1)
- Young Adult (1)
- Adolescent (1)
- Adult (1)
- Anti-HIV Agents (1)
- COVID-19 (1)
- District of Columbia (1)
- Emtricitabine (1)
- Heterocyclic Compounds, 3-Ring (1)
- HIV Infections (1)
- HIV Integrase Inhibitors (1)
- Homosexuality, Male (1)
- Humans (1)
- Integrases (1)
- K-12 schools (1)
- Male (1)
- Middle Aged (1)
- Pyridones (1)
- racial/ethnicity disparities (1)
- Sexual and Gender Minorities (1)
- time-to-event (1)
- vaccine hesitancy (1)
- Young Adult (1)
- :Haaland, Richard E. ;Martin, AmyJul 17 2017 | AIDS. 31(11):1647-1650.
- :Haaland, Richard E. ;Martin, Amy10 2021 | AIDS Res Hum Retroviruses. 37(10):744-747:Point-of-care (POC) tests for antiretroviral drugs (ARVs) could help improve individual adherence. This study sought to define the utility of urine, b...
- :Haaland, Richard E. ;Martin, AmyNovember 01 2019 | J Acquir Immune Defic Syndr. 82(3):252-256:Background:Urine provides a minimally invasive specimen that may allow for development of rapid tests to detect antiretroviral drugs and provide oppor...
- :Mark-Carew, Miguella ;van Zyl, André12 2023 | J Sch Health. 93(12):1079-1090:ObjectiveDespite widespread availability of COVID-19 vaccines, millions of Americans have not received the recommended vaccine doses. In the District ...
- :Haaland, Richard E ;Fountain, JeffreyOct 2018 | J Int AIDS Soc. 21(10).:IntroductionOral pre‐exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is highly effective in preventing ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.